Pharmaceutical Vials Market Size, Share, Growth, Trends, and Global Industry Analysis: By Vial Type (Amber vial and Clear vial), By Capacity (Up to 10 ml, 11-50 ml, 51-100 ml, and Above 100 ml), By Material Type ((Glass, (Type 1, Type 2, & Type 3), Plastic (Polyethylene (PE), Polypropylene (PP), Poly Vinyl Chloride (PVC), & Others), Cyclic Olefin Polymer (COP), and Cyclic Olefin Copolymer (COC)), By Application (Nasal, Oral, and Others), By End Users (Hospital, Drug Manufacturing, Biopharmaceutical company, and Compound pharmacy), and Region Forecast 2019-2030

The pharmaceutical vials market was valued at USD 15,683.3 million in 2023 and is expected to grow at a CAGR of 6.9% over the forecast year to reach USD 25,019.7 million in 2030. These are being taken as a scientific sample vessel for testing in labs, which are also put into an autosampler device. Pharmaceutical vials also help a person to consume their medicines at the right time with perfect dosages. Increases in demand for injectable drugs and biologics boost the market; these drugs and biologics require safe and reliable packaging solutions. Increasing regulatory requirements related to the packaging of drugs as well as investment in the pharmaceutical industry further accelerates market growth.

However, this market holds certain restraints, such as high production costs and issues associated with the fragility of glass vials that could break and lead to contamination. The innovative materials area is full of potential, particularly the development of polymer vials with increased strength and weight reduction. There are increasing trends in personalized medicine, wherein consumers require small batch sizes as well as customized packaging solutions. This, in all respects, clearly elaborates on the growing importance of advanced packaging in the pharmaceutical market.

 Pharmaceutical Vials Market Key Developments

• In February 2022, Bormioli Pharma announced a string of collaborations aimed at improving the sustainability and performance levels of glass used in the pharmaceutical industry, strengthening bottles' resistance to chemical agents, and reducing carbon emissions in the glass-making process.
• In June 2021, The U.S. Food and Drug Administration FDA granted tentative approval received by Zydus Cadila Healthcare to market "pemetrexed" in 500 mg/vial, 100mg/vial, and 1000 mg/vial, and single-dose vials for injection.